Acura Pharmaceuticals, Inc. (ACUR) Reports Q4 Loss of $0.03/Share
Tweet
Share
E-mailGet Alerts ACUR Hot Sheet
Price: $0.00 --0%
Financial Fact:
Total operating expenses: 2.29M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
Total operating expenses: 2.29M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) reported Q4 EPS of ($0.03), versus ($0.06) reported last year.
For earnings history and earnings-related data on Acura Pharmaceuticals, Inc. (ACUR) click here.
For earnings history and earnings-related data on Acura Pharmaceuticals, Inc. (ACUR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo upgrades S&P 500 Industrials to favorable
- Argan (AGX) PT Lowered to $785 at JPMorgan, Current Levels Seen as 'Very Attractive'
- UBS names top European chip stocks to watch ahead of Q3 2026 earnings season
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
